Neutralizing nanobodies could significantly inhibit SARS-CoV-2 pseudoviruses infection in host HEK293T-ACE2 cells through blocking spike protein interaction with ACE2 by targeting RBD (Scheme 1c). Here, ACE2 is linked to severe acute respiratory syndrome.